Use of polyomavirus-like particles for development of vaccine as a supportive treatment of chronic myeloid leukemia

Abstract

Development of vaccine for treatment of CML based on insertion of CML-specific antigens into sequences of structural proteins of mouse polyomavirus

Keywords

• polyomavirus
• virus-like particles
• chronic myeloid leukemia